title: Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?
authors.forename: Behnood
authors.initials: B
authors.lastname: Bikdeli
authors.forename: Kelly M
authors.initials: KM
authors.lastname: Strait
authors.forename: Kumar
authors.initials: K
authors.lastname: Dharmarajan
authors.forename: Chohreh
authors.initials: C
authors.lastname: Partovian
authors.forename: Steven G
authors.initials: SG
authors.lastname: Coca
authors.forename: Nancy
authors.initials: N
authors.lastname: Kim
authors.forename: Shu-Xia
authors.initials: SX
authors.lastname: Li
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Testani
authors.forename: Usman
authors.initials: U
authors.lastname: Khan
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
mesh_terms: D016208:Databases, Factual; D005260:Female; D005500:Follow-Up Studies; D005665:Furosemide / Q000627:therapeutic use*; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012720:Severity of Illness Index; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D016019:Survival Analysis; D000077786:Torsemide; D016896:Treatment Outcome
chemical_list: D049994:Sodium Potassium Chloride Symporter Inhibitors; D013449:Sulfonamides; D005665:Furosemide; D000077786:Torsemide